Treatment of Chronic Lymphocytic Leukemia

Review covers B-cell receptor signaling and the pathogenesis, chemoimmunotherapy, kinase inhibitors, BTK inhibitors, cardiac arrhythmias, fungal infections, and bleeding with BTK inhibitors, PI3K inhibitors, BCL2 antagonist resistance to the novel agents, and cellular therapy.

Source:

New England Journal of Medicine